The malignant thymoma –the problem of many fields
Thymom – mezioborový problém
Autoři prezentují v kazuistice pacientku s ojediněle se vyskytujícím thymomem, jeho klinické projevy,diagnostické a terapeutické možnosti. Kazuistika tímto způsobem upozorňuje i na problematiku diferenciálnídiagnostiky nádorů mezihrudí.
Klíčová slova:
 nádory mezihrudí, thymom
																	
									Authors:
											L. Slováček						1; 											M. Blažek						2; 											L. Jebavý						1; 											J. Kačerovský						1; 											J. Horáček						1										
				
									Authors‘ workplace:
											Katedra válečného vnitřního lékařství VLA J. E. Purkyně, Hradec Králové
						1										
				
									Published in:
					Transfuze Hematol. dnes,, 2003, No. 4, p. 166-169.
					
				
									Category:
					
					
				
							
Overview
The authors prepared for the presentation a case report of the pacient with a rare tumor of the thymom.The case report points on the differential diagnosis of the tumors of the mediastinum.
Key words:
 tumors of the mediastinum, thymoma
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2003 Issue 4
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
 - Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
 - Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
 - Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
 - Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
 
Most read in this issue
- Imatinib (Glivec®) in the treatment of patients withaccelerated phase of chronic myelogenous leukaemia and Ph-positive acute lymphoblasticleukaemia
 - Non-invasive fetalRHD genotyping on DNA isolated from maternal plasmain RhD negative pregnancies
 - The malignant thymoma –the problem of many fields
 - The efficiency of monoclonal antibody anti-CD20 – rituximab –in the treatment of folicular lymphoma